FDA Drug recall D-0906-2018
Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL Carpuject Single-use cartridge syringe, Single unit (NDC 0409-1782-03) and…
- FDA Drug
- Class I
- terminated
- Published 2018-06-13
On 2018-06-13 the FDA classified a Class I recall of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL Carpuject Single-use cartridge syringe, Single unit (NDC 0409-1782-03) and… by Hospira Lake Forest, citing presence of Particulate Matter; Potential for particulate matter on the syringe plunger.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0906-2018 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2018-06-04 |
| Published | 2018-06-13 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Hospira Lake Forest |
| Distribution | US |
Product
Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL Carpuject Single-use cartridge syringe, Single unit (NDC 0409-1782-03) and 10 count box (NDC 0409-1782-69), Rx Only, Hospira Inc., Lake Forest, IL
Reason
Presence of Particulate Matter; Potential for particulate matter on the syringe plunger.
Identifiers
| ndc | 0409-1782-03 |
|---|---|
| ndc | 0409-1782-69 |
| code_info | 72680LL, Exp. 1DEC2018 (NDC 0409-1782-03); 76510LL, Exp. 1APR2019 (NDC 0409-1782-69) |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0906-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.